Monoclonal Antibody Therapeutics Market

A type of immunotherapy known as monoclonal antibody therapy uses monoclonal antibodies (mAb) to bind mono selectively to particular cells or proteins. Therapeutic monoclonal antibodies use the adaptive immune system's highly developed specificity to combat illness. Chronic and severe diseases are being treated with monoclonal antibodies. 

Furthermore, the rising incidence of osteoporosis or arthritis, the expansion of the therapeutic pipeline, investments by Biotechnology and pharmaceutical companies in research and development, and the launch of more advanced and novel products are all contributing factors to the growth of the global market for monoclonal antibody therapeutics.